Brief: Modex Therapeutics Secures $35 mln Barda Supplement To Develop Covid Multispecific Antibodies
07/10/2024 13:22
Oct 7 (Reuters) - OPKO Health Inc OPK.O :
* MODEX THERAPEUTICS SECURES $35 MILLION BARDA SUPPLEMENT TO
DEVELOP COVID MULTISPECIFIC ANTIBODIES AND $16 MILLION TO
INITIATE INFLUENZA PROGRAM
Source text for Eikon: ID:nGNX6r7Kz5
Further company coverage: OPK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OPKO Health
See all newsOpko Health, Inc. Expected To Post A Loss Of 7 Cents A Share: Earnings Preview
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
US RESEARCH ROUNDUP-Bank7, Goldman Sachs, Morgan Stanley
Deals of the day-Mergers and acquisitions
US STOCKS ON THE MOVE-Caterpillar, Kimberly-Clark, Bending Spoons